SEC Tracker
Get the app

Ludwig Enterprises LUDG

Ludwig Enterprises Q2 FY25: net loss $649K; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Ludwig Enterprises reported for Q2 FY25, the quarter ended Jun 30, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$649KAgainst −$364K in Q2 FY2410-Q income statement, on EDGAR
  2. Diluted EPS$0.00Against $0.00 in Q2 FY2410-Q income statement, on EDGAR
  3. Cash and cash equivalents$142K−29% from $202K in Q2 FY2410-Q balance sheet, on EDGAR
  4. Cash from operations−$411KAgainst −$229K in Q2 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Ludwig Enterprises files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. CapForce CFOR public float $12M, Jun 30, 2025
  2. American Shared Hospital Services AMS public float $12M, Jun 30, 2025
  3. Biodesix BDSX public float $20M, Jun 30, 2025
  4. BioNexus Gene Lab BGLC public float $5M, Jun 30, 2025
  5. Aclarion ACON public float $4M, Jun 30, 2025